PGEN
Precigen, Inc. NASDAQ Listed Aug 8, 2013$5.37
-0.25%
vs $5.38
Mkt Cap $1.6B
52w Low $1.39
94.7% of range
52w High $5.59
50d MA $4.19
200d MA $4.03
P/E (TTM)
—
EV/EBITDA
—
P/B
78.2x
Debt/Equity
0.2x
ROE
-1198.6%
P/FCF
-18.2x
RSI (14)
72.80
ATR (14)
$0.31
Beta
1.12
50d MA
$4.19
200d MA
$4.03
Avg Volume
5.0M
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorporates advanced DNA construction technologies and computational models to design and assemble genetic components into complex gene expression programs; mbIL15, a gene that enhances functional characteristics of immune cells; Sleeping Beauty, a non-viral transposon/transposase system; AttSite recombinases, which breaks and rejoins DNA at specific sequences; AdenoVerse technology platform, a library of engineered adenovector serotypes; and L. lactis is a food-grade bacterium. Additionally, it provides RheoSwitch, an inducible gene switch system that provides quantitative dose-proportionate regulation of the amount and timing of target protein expression; kill switches to selectively eliminate cell therapies in vivo; tissue-specific promoters; UltraCAR-T platform for the treatment of cancer; AdenoVerse Immunotherapy, a library of proprietary adenovectors for the gene delivery; and ActoBiotics platform, genetically modified bacteria that deliver proteins and peptides at mucosal sites. Precigen, Inc. has collaboration and license agreements with Alaunos Therapeutics, Inc.; Ares Trading S.A.; Oragenics, Inc.; Castle Creek Biosciences, Inc.; Intrexon Energy Partners, LLC; and Intrexon Energy Partners II, LLC. The company was formerly known as Intrexon Corporation and changed its name to Precigen, Inc. in January 2020. Precigen, Inc. was founded in 1998 and is based in Germantown, Maryland.
20374 Seneca Meadows Parkway · Germantown, MD 20876 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 25, 2026 | AMC | -0.10 | -0.01 | +90.0% | 3.10 | +31.3% | +25.5% | -5.7% | -11.4% | +19.1% | +1.6% | — |
| Nov 13, 2025 | AMC | -0.08 | -0.11 | -37.5% | 3.86 | -2.1% | +25.6% | +1.0% | -1.0% | -13.0% | -7.6% | — |
| Aug 12, 2025 | AMC | -0.14 | -0.11 | +21.4% | 1.80 | +1.7% | +6.1% | -3.1% | +58.9% | +0.3% | +9.2% | — |
| May 14, 2025 | AMC | -0.08 | -0.07 | +12.5% | 1.28 | -0.8% | +2.3% | +10.7% | -6.2% | +3.7% | -6.4% | — |
| Mar 19, 2025 | AMC | -0.06 | -0.04 | +33.3% | 1.79 | -0.6% | +0.6% | +0.6% | +0.6% | -6.0% | -5.8% | — |
| Nov 14, 2024 | AMC | -0.08 | -0.09 | -12.5% | 0.88 | +4.2% | -7.1% | -3.4% | +0.4% | +5.2% | +7.9% | — |
| Aug 14, 2024 | AMC | -0.09 | -0.10 | -11.1% | 1.12 | -1.8% | -4.5% | +1.9% | +5.5% | -1.7% | +5.3% | — |
| May 14, 2024 | AMC | -0.09 | -0.10 | -11.1% | 1.37 | +0.7% | +5.1% | -2.8% | -1.4% | +0.7% | +0.0% | — |
| Feb 13, 2024 | AMC | -0.08 | -0.13 | -62.5% | 1.31 | +2.3% | +6.9% | +2.1% | -0.7% | +0.0% | +0.0% | — |
| Nov 9, 2023 | AMC | -0.08 | -0.08 | +0.0% | 1.26 | -3.2% | -13.5% | -18.3% | +13.5% | +5.0% | +8.5% | — |
| Aug 9, 2023 | AMC | -0.10 | -0.08 | +20.0% | 1.24 | -2.4% | +22.6% | +1.3% | +7.8% | -7.8% | -1.0% | — |
| May 10, 2023 | AMC | -0.08 | -0.10 | -25.0% | 1.21 | +0.0% | -5.8% | -7.0% | +14.2% | +0.8% | +0.8% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 26 | Citizens | Maintains | Market Outperform → Market Outperform | — | $3.10 | $4.07 | +31.3% | +25.5% | -5.7% | -11.4% | +19.1% | +1.6% |
| Mar 26 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $3.10 | $4.07 | +31.3% | +25.5% | -5.7% | -11.4% | +19.1% | +1.6% |
| Nov 14 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $3.86 | $3.78 | -2.1% | +25.6% | +1.0% | -1.0% | -13.0% | -7.6% |
| Aug 19 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $2.95 | $2.95 | +0.0% | +9.2% | -0.3% | +13.4% | +14.8% | -4.8% |
| Aug 19 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $2.95 | $2.95 | +0.0% | +9.2% | -0.3% | +13.4% | +14.8% | -4.8% |
| Aug 15 | JP Morgan | Upgrade | Underweight → Neutral | — | $1.85 | $2.60 | +40.5% | +58.9% | +0.3% | +9.2% | -0.3% | +13.4% |
| Aug 15 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $1.85 | $2.60 | +40.5% | +58.9% | +0.3% | +9.2% | -0.3% | +13.4% |
| Aug 13 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $1.80 | $1.83 | +1.7% | +6.1% | -3.1% | +58.9% | +0.3% | +9.2% |
| Jun 12 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $1.50 | $1.50 | +0.0% | +1.3% | +0.0% | +1.3% | -7.8% | +4.9% |
| May 15 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $1.28 | $1.27 | -0.8% | +2.3% | +10.7% | -6.2% | +3.7% | -6.4% |
| Mar 20 | Citizens Capital Markets | Maintains | Market Outperform → Market Outperform | — | $1.79 | $1.78 | -0.6% | +0.6% | +0.6% | +0.6% | -6.0% | -5.8% |
| Mar 20 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $1.79 | $1.78 | -0.6% | +0.6% | +0.6% | +0.6% | -6.0% | -5.8% |
| Jan 23 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $1.13 | $1.18 | +4.4% | +18.6% | +3.7% | -6.5% | -2.3% | +2.4% |
| Jan 22 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $1.18 | $1.16 | -1.7% | -4.2% | +18.6% | +3.7% | -6.5% | -2.3% |
| Jan 14 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $1.07 | $1.10 | +2.8% | +1.9% | +3.7% | -1.8% | +0.0% | +6.3% |
| Nov 15 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $0.88 | $0.92 | +4.2% | -7.1% | -3.4% | +0.4% | +5.2% | +7.9% |
| Aug 15 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $1.12 | $1.10 | -1.8% | -4.5% | +1.9% | +5.5% | -1.7% | +5.3% |
| Aug 15 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $1.12 | $1.10 | -1.8% | -4.5% | +1.9% | +5.5% | -1.7% | +5.3% |
| Jun 4 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $1.56 | $1.57 | +0.6% | +5.8% | +6.1% | -2.3% | -5.3% | +4.9% |
| Jun 3 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $1.40 | $1.45 | +3.6% | +11.4% | +5.8% | +6.1% | -2.3% | -5.3% |
| Jun 3 | Stifel | Maintains | Buy → Buy | — | $1.40 | $1.45 | +3.6% | +11.4% | +5.8% | +6.1% | -2.3% | -5.3% |
| May 15 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $1.37 | $1.38 | +0.7% | +5.1% | -2.8% | -1.4% | +0.7% | +0.0% |
| May 15 | Stifel | Maintains | Buy → Buy | — | $1.37 | $1.38 | +0.7% | +5.1% | -2.8% | -1.4% | +0.7% | +0.0% |
| Mar 22 | JP Morgan | Downgrade | Neutral → Underweight | — | $1.53 | $1.44 | -5.9% | -8.5% | +0.7% | -0.7% | +3.6% | +0.0% |
| Mar 20 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $1.44 | $1.41 | -2.1% | +0.0% | +6.2% | -8.5% | +0.7% | -0.7% |
| Mar 20 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $1.44 | $1.41 | -2.1% | +0.0% | +6.2% | -8.5% | +0.7% | -0.7% |
| Aug 10 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $1.24 | $1.21 | -2.4% | +22.6% | +1.3% | +7.8% | -7.8% | -1.0% |
| Jun 5 | JMP Securities | Maintains | Market Outperform → Outperform | — | $1.29 | $1.25 | -3.1% | +3.9% | -3.0% | +1.5% | -4.5% | -6.3% |
| May 23 | JP Morgan | Maintains | Neutral → Neutral | — | $1.31 | $1.27 | -3.1% | +6.9% | -5.7% | -9.1% | +1.7% | +0.8% |
| May 11 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $1.21 | $1.21 | +0.0% | -5.8% | -7.0% | +14.2% | +0.8% | +0.8% |
| May 11 | JMP Securities | Maintains | Market Outperform → Outperform | — | $1.21 | $1.21 | +0.0% | -5.8% | -7.0% | +14.2% | +0.8% | +0.8% |
| Mar 7 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $1.15 | $1.18 | +2.6% | +17.4% | -5.2% | -8.6% | -6.8% | +0.0% |
| Mar 7 | JMP Securities | Maintains | Market Outperform → Outperform | — | $1.15 | $1.18 | +2.6% | +17.4% | -5.2% | -8.6% | -6.8% | +0.0% |
| Jan 30 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $1.64 | $1.66 | +1.2% | -4.9% | +3.8% | +4.3% | +7.7% | +0.5% |
| Nov 18 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $1.85 | $1.99 | +7.6% | +5.9% | -2.0% | +1.0% | +4.1% | -5.0% |
| Nov 14 | JMP Securities | Maintains | Market Outperform → Outperform | — | $1.84 | $1.80 | -2.2% | +2.7% | +3.2% | -6.2% | +1.1% | +5.9% |
| Nov 10 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $1.47 | $1.57 | +6.8% | +21.1% | +3.4% | +2.7% | +3.2% | -6.2% |
| Aug 9 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $2.05 | $2.13 | +3.9% | +12.7% | +4.8% | -4.1% | +2.2% | +10.5% |
| Feb 25 | Stifel | Maintains | Buy → Buy | — | $8.57 | $8.79 | +2.6% | -3.3% | +1.8% | -2.8% | +4.6% | -2.0% |
| Feb 22 | Wells Fargo | Maintains | Overweight → Overweight | — | $7.81 | $8.02 | +2.6% | +5.2% | +0.6% | +3.6% | -3.3% | +1.8% |
| Dec 16 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $7.17 | $7.20 | +0.4% | +4.5% | +9.3% | +17.6% | +3.4% | +5.4% |
| May 8 | H.C. Wainwright | Maintains | Buy → Buy | — | $3.17 | $3.27 | +3.2% | +2.8% | -0.9% | -7.7% | -4.7% | -8.5% |
| Aug 9 | BofA Securities | Maintains | Underperform → Underperform | — | $7.62 | $6.61 | -13.3% | -8.8% | +0.0% | -3.3% | -2.7% | +1.5% |
| Mar 1 | Northland Securities | Downgrade | Outperform → Perform | — | $7.97 | $6.04 | -24.2% | -36.5% | -18.2% | +21.3% | -8.2% | +9.1% |
| Oct 10 | JMP Securities | Maintains | Market Outperform → Outperform | — | $15.76 | $15.85 | +0.6% | +1.8% | -5.9% | +0.1% | -4.6% | +5.1% |
| Jul 16 | BofA Securities | Downgrade | Neutral → Underperform | — | $15.38 | $14.32 | -6.9% | -5.3% | +0.5% | -2.0% | +2.2% | +0.5% |
| Mar 5 | JP Morgan | Maintains | Neutral → Neutral | — | $16.09 | $16.00 | -0.6% | -3.2% | +1.0% | +0.8% | -0.3% | +5.9% |
| Mar 2 | BofA Securities | Maintains | Neutral → Neutral | — | $12.90 | $13.28 | +2.9% | +24.7% | -3.2% | +1.0% | +0.8% | -0.3% |
| Nov 10 | BofA Securities | Maintains | Neutral → Neutral | — | $15.88 | $15.04 | -5.3% | -25.6% | +6.5% | +0.8% | -0.2% | +7.7% |
| May 3 | JMP Securities | Maintains | Market Outperform → Outperform | — | $27.27 | $27.22 | -0.2% | -4.7% | -4.8% | +1.6% | +3.3% | +3.8% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| May 28, 2026 | Sabzevari HelenOff | President and CEO | Sell | 119,250 | $4.36 | $520K | 3,768,872 | -6.31% | -0.28% |
| May 28, 2026 | Lehr Donald P.Off | Chief Legal Officer | Sell | 29,131 | $4.36 | $127K | 755,461 | -6.31% | -0.28% |
| May 28, 2026 | Shah Rutul ROff | Chief Operating Officer | Sell | 42,703 | $4.36 | $186K | 497,751 | -6.31% | -0.28% |
| May 28, 2026 | Tennant PhilOff | Chief Commercial Officer | Sell | 30,272 | $4.36 | $132K | 139,369 | -6.31% | -0.28% |
| May 28, 2026 | Thomasian Harry Jr.Off | Chief Financial Officer | Sell | 41,884 | $4.36 | $183K | 554,535 | -6.31% | -0.28% |
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Patient Capital Management, Llc | 17,817,387 | $69M | Reduced | Mar 2026 |
| 2 | Vanguard Capital Management Llc | 7,148,996 | $28M | New | Mar 2026 |
| 3 | Morgan Stanley | 6,387,046 | $27M | Added | Dec 2025 |
| 4 | Point72 Asset Management | 6,644,361 | $26M | Reduced | Mar 2026 |
| 5 | Tang Capital Management Llc | 5,617,500 | $23M | Reduced | Dec 2025 |
| 6 | Iridian Asset Management Llc/ct | 3,592,730 | $14M | — | Mar 2026 |
| 7 | Citadel Advisors Llc | 2,702,383 | $10M | Reduced | Mar 2026 |
| 8 | Franklin Resources Inc | 2,633,780 | $10M | Added | Mar 2026 |
| 9 | Vanguard Portfolio Management Llc | 2,116,011 | $8M | New | Mar 2026 |
| 10 | Fmr Llc | 1,998,596 | $8M | Reduced | Mar 2026 |
| 11 | Northern Trust Corp | 1,611,790 | $6M | Added | Mar 2026 |
| 12 | Bank Of America Corp /de/ | 1,471,279 | $6M | Reduced | Mar 2026 |
| 13 | Woodline Partners Lp | 1,401,412 | $5M | — | Mar 2026 |
| 14 | Prelude Capital Management, Llc | 1,270,053 | $5M | Added | Mar 2026 |
| 15 | Jpmorgan Chase & Co | 873,283 | $3M | Reduced | Mar 2026 |
| 16 | Boxer Capital Management, Llc | 850,000 | $3M | New | Sep 2025 |
| 17 | Hrt Financial Lp | 710,777 | $3M | New | Mar 2026 |
| 18 | Ubs Group Ag | 686,084 | $3M | Reduced | Mar 2026 |
| 19 | Nuveen, Llc | 534,011 | $2M | Added | Mar 2026 |
| 20 | Barclays Plc | 491,696 | $2M | Reduced | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$1.61B
Enterprise Value
$1.54B
P/E (TTM)
—
Forward P/E
—
PEG Ratio
-0.03x
P/B
78.23x
P/S
51.76x
P/FCF
-18.25x
EV/EBITDA
—
Shares Out
304.7M
Financials (TTM)
Revenue
$31.6M
Net Income
-$204.4M
EBITDA
-$195.2M
Free Cash Flow
-$89.8M
Op Cash Flow
-$87.8M
EPS Basic
$-1.41
EPS Diluted
$-1.28
EPS Forward
$-0.05
Gross Margin
75.6%
Op Margin
-297.2%
Net Margin
—
Balance Sheet
Total Assets
$156.6M
Total Liab.
$135.7M
Total Equity
$20.9M
Cash
$97.9M
LT Debt
$0
Book Value/Sh
$0.07
Debt/Equity
0.24x
Current Ratio
3.09
Quick Ratio
2.83
Returns & Growth
ROE
-1198.6%
ROA
-161.2%
ROIC
-88.5%
Rev Growth YoY
+146.7%
EPS Growth YoY
-200.0%
Price Returns
2W
-5.7%
1M
+4.3%
3M
+14.5%
6M
+13.3%
12M
+228.8%
Technicals
52W High
$5.59
52W Low
$1.39
50d MA
$4.19
200d MA
$4.03
RSI (14)
72.80
ATR (14)
$0.31
Beta
1.12
Avg Volume
5.0M
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
$6.00
High
$6.00
Low
$6.00
Median
$6.00
Data updated apr 26, 2026 7:29pm
· Source: financialmodelingprep.com